solo per uso di ricerca

ZM 447439 Inibitore di Aurora A/B

N. Cat.: S1103

ZM 447439 è un inibitore selettivo e ATP-competitivo per Aurora A e Aurora B con IC50 di 110 nM e 130 nM, rispettivamente. È più di 8 volte selettivo per Aurora A/B rispetto a MEK1, Src, Lck e ha scarso effetto contro CDK1/2/4, Plk1, Chk1, ecc.
ZM 447439 Aurora Kinase Inibitore Chemical Structure

Struttura chimica

Peso molecolare: 513.59

Vai a

Controllo Qualità (Quality Control)

Lotto: Purezza: 99.26%
99.26

Coltura cellulare, trattamento e concentrazione di lavoro
(Cell Culture, Treatment & Working Concentration)

Linee cellulari Tipo di saggio Concentrazione Tempo di incubazione Formulazione Descrizione dell'attività PMID
human EoL-1-cell Growth inhibition assay Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50=0.18678 μM
MCF7 cell Proliferation assay Antiproliferative activity against MCF7 cell line, IC50=0.198 μM
human P12-ICHIKAWA cell Growth inhibition assay Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50=0.22441 μM
human KARPAS-45 cell Growth inhibition assay Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50=0.38128 μM
human ES3 cell Growth inhibition assay Inhibition of human ES3 cell growth in a cell viability assay, IC50=0.4732 μM
human ES8 cell Growth inhibition assay Inhibition of human ES8 cell growth in a cell viability assay, IC50=0.49806 μM
human TE-11 cell Growth inhibition assay Inhibition of human TE-11 cell growth in a cell viability assay, IC50=0.53703 μM
human RS4-11 cell Growth inhibition assay Inhibition of human RS4-11 cell growth in a cell viability assay, IC50=0.5544 μM
human MOLT-16 cell Growth inhibition assay Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50=0.60961 μM
human RKO cell Growth inhibition assay Inhibition of human RKO cell growth in a cell viability assay, IC50=0.70656 μM
human MV-4-11 cell Growth inhibition assay Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50=0.7963 μM
human SW954 cell Growth inhibition assay Inhibition of human SW954 cell growth in a cell viability assay, IC50=0.83635 μM
human BE-13 cell Growth inhibition assay Inhibition of human BE-13 cell growth in a cell viability assay, IC50=0.84418 μM
human MOLT-4 cell Growth inhibition assay Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50=0.89978 μM
human NBsusSR cell Growth inhibition assay Inhibition of human NBsusSR cell growth in a cell viability assay, IC50=0.91387 μM
human H9 cell Growth inhibition assay Inhibition of human H9 cell growth in a cell viability assay, IC50=0.92979 μM
human A172 cell Growth inhibition assay Inhibition of human A172 cell growth in a cell viability assay, IC50=0.98411 μM
human ES5 cell Growth inhibition assay Inhibition of human ES5 cell growth in a cell viability assay, IC50=1.00248 μM
human SBC-1 cell Growth inhibition assay Inhibition of human SBC-1 cell growth in a cell viability assay, IC50=1.03928 μM
human NCI-H209 cell Growth inhibition assay Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50=1.16602 μM
human NKM-1 cell Growth inhibition assay Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=1.16798 μM
human NCI-H720 cell Growth inhibition assay Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50=1.20627 μM
human KE-37 cell Growth inhibition assay Inhibition of human KE-37 cell growth in a cell viability assay, IC50=1.21388 μM
human SW48 cell Growth inhibition assay Inhibition of human SW48 cell growth in a cell viability assay, IC50=1.23155 μM
human IST-SL1 cell Growth inhibition assay Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50=1.31727 μM
human SK-NEP-1 cell Growth inhibition assay Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50=1.36498 μM
human NOMO-1 cell Growth inhibition assay Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50=1.36725 μM
human DOHH-2 cell Growth inhibition assay Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50=1.40276 μM
human ABC-1 cell Growth inhibition assay Inhibition of human ABC-1 cell growth in a cell viability assay, IC50=1.40352 μM
human Ramos-2G6-4C10 cell Growth inhibition assay Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50=1.40605 μM
human EM-2 cell Growth inhibition assay Inhibition of human EM-2 cell growth in a cell viability assay, IC50=1.41721 μM
human NB14 cell Growth inhibition assay Inhibition of human NB14 cell growth in a cell viability assay, IC50=1.55621 μM
human MOLT-13 cell Growth inhibition assay Inhibition of human MOLT-13 cell growth in a cell viability assay, IC50=1.56706 μM
human ECC10 cell Growth inhibition assay Inhibition of human ECC10 cell growth in a cell viability assay, IC50=1.63353 μM
human LK-2 cell Growth inhibition assay Inhibition of human LK-2 cell growth in a cell viability assay, IC50=1.64594 μM
human CTB-1 cell Growth inhibition assay Inhibition of human CTB-1 cell growth in a cell viability assay, IC50=1.67082 μM
human NCI-H1581 cell Growth inhibition assay Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50=1.6755 μM
human COLO-800 cell Growth inhibition assay Inhibition of human COLO-800 cell growth in a cell viability assay, IC50=1.70382 μM
human NB7 cell Growth inhibition assay Inhibition of human NB7 cell growth in a cell viability assay, IC50=1.75297 μM
human LAMA-84 cell Growth inhibition assay Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50=1.7552 μM
human HCT-116 cells Growth inhibition assay Inhibition of human HCT-116 cell growth in a cell viability assay, IC50=1.80908 μM
SK-UT-1 cell Growth inhibition assay Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50=1.8153 μM
human H4 cell Growth inhibition assay Inhibition of human H4 cell growth in a cell viability assay, IC50=1.81578 μM
human CAL-51 cell Growth inhibition assay Inhibition of human CAL-51 cell growth in a cell viability assay, IC50=1.83845 μM
human LoVo cells Proliferation assay 72 h Antiproliferative activity against human LoVo cells after 72 hrs by MTT-based WST8 reagent assay, IC50=1.9 μM
human HN cell Growth inhibition assay Inhibition of human HN cell growth in a cell viability assay, IC50=1.9251 μM
human L-363 cell Growth inhibition assay Inhibition of human L-363 cell growth in a cell viability assay, IC50=1.9512 μM
human NCI-H747 cell Growth inhibition assay Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=2.03353 μM
human A498 cell Growth inhibition assay Inhibition of human A498 cell growth in a cell viability assay, IC50=2.3669 μM
Clicca per visualizzare più dati sperimentali sulle linee cellulari

Informazioni chimiche, conservazione e stabilità (Chemical Information, Storage & Stability)

Peso molecolare 513.59 Formula

C29H31N5O4

Conservazione (Dalla data di ricezione)
N. CAS 331771-20-1 Scarica SDF Conservazione delle soluzioni stock

Sinonimi N/A Smiles COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5

Solubilità (Solubility)

In vitro
Lotto:

DMSO : 103 mg/mL (200.54 mM)
(Il DMSO contaminato da umidità può ridurre la solubilità. Utilizzare DMSO fresco e anidro.)

Water : Insoluble

Ethanol : Insoluble

Calcolatore di Molarità

Massa Concentrazione Volume Peso molecolare
Calcolatore di Diluizione Calcolatore del Peso Molecolare

In vivo
Lotto:

Calcolatore di formulazione in vivo (Soluzione chiara)

Passo 1: Inserire le informazioni di seguito (Consigliato: Un animale aggiuntivo per tenere conto della perdita durante l'esperimento)

mg/kg g μL

Passo 2: Inserire la formulazione in vivo (Questo è solo il calcolatore, non la formulazione. Contattateci prima se non c'è una formulazione in vivo nella sezione Solubilità.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Risultati del calcolo:

Concentrazione di lavoro: mg/ml;

Metodo per preparare il liquido master di DMSO: mg farmaco predissolto in μL DMSO ( Concentrazione del liquido master mg/mL, Vi preghiamo di contattarci prima se la concentrazione supera la solubilità del DMSO del lotto del farmaco. )

Metodo per preparare la formulazione in vivo: Prendere μL DMSO liquido master, quindi aggiungereμL PEG300, mescolare e chiarire, quindi aggiungereμL Tween 80, mescolare e chiarire, quindi aggiungere μL ddH2O, mescolare e chiarire.

Metodo per preparare la formulazione in vivo: Prendere μL DMSO liquido master, quindi aggiungere μL Olio di mais, mescolare e chiarire.

Nota: 1. Si prega di assicurarsi che il liquido sia limpido prima di aggiungere il solvente successivo.
2. Assicurarsi di aggiungere il/i solvente/i in ordine. È necessario assicurarsi che la soluzione ottenuta, nell'aggiunta precedente, sia una soluzione limpida prima di procedere all'aggiunta del solvente successivo. Metodi fisici come il vortex, gli ultrasuoni o il bagno d'acqua calda possono essere utilizzati per facilitare la dissoluzione.

Meccanismo d'azione (Mechanism of Action)

Caratteristiche
An Aurora selective ATP-competitive inhibitor.
Targets/IC50/Ki
Aurora A
(Cell-free assay)
110 nM
Aurora B
(Cell-free assay)
130 nM
LCK
(Cell-free assay)
880 nM
Src
(Cell-free assay)
1.03 μM
MEK1
(Cell-free assay)
1.79 μM
In vitro

In vitro, ZM-447439 selectively inhibits recombinant human Aurora A and B with IC50 values of 110 and 130 nM, respectively, while other protein kinases of diverse structural types including the mitotic kinases CDK1 and PLK1 are inhibited with IC50 values >10 μM. Aurora kinase inhibitor, ZM-447439 time- and dose-dependently inhibits the growth of all three cell lines with IC50 values of 3 μM (BON), 0.9 μM (QGP-1) and 3 μM (MIP-101) after 72 hours of continuous exposure. In addition, ZM-447439 potently induces cell apoptosis by promoting DNA fragmentation and caspase 3 and 7 activation, and arrests GEP-NET cells in the G0 /G1and G2/M phase of the cell cycle. In mouse embryo, inhibition of Aurora kinase activity by ZM-447439 results in abnormalities during mitosis by regulating the phosphorylation of histone H3 serine 10 (H3S10Ph) from G2 to metaphase with different perturbations in each embryonic cycle. A recent study shows that ZM-447439 exhibits growth inhibitory and proapoptotic effect on cervical cancer SiHa cells, and enhances the chemosensitivity.

Saggio chinasico
Saggi chinasici in vitro
Le Aurora A e B ricombinanti sono espresse come proteine di fusione marcate con His6 N-terminale usando un sistema di espressione baculovirale. Aurora A è purificata mediante cromatografia di affinità usando agarosio Ni-NTA, e Aurora B è purificata mediante cromatografia a scambio ionico usando CM Sepharose Fast Flow. 1 ng di enzima ricombinante purificato viene aggiunto a un cocktail di reazione contenente 25 mM Tris-HCl, pH 7,5, 12,5 mM KCl, 2,5 mM NaF, 0,6 mM DTT, 6,25 mM MnCl2, 10 μM di substrato peptidico, 10 μM per Aurora A o 5 μM ATP per Aurora B, e 0,2 μCi γ-[33P]ATP (attività specifica ≥2.500 Ci/mmol), e quindi incubato a RT per 60 minuti. Le reazioni vengono interrotte dall'aggiunta di acido fosforico al 20%, e i prodotti vengono catturati su filtri di nitrocellulosa P30 e analizzati per l'incorporazione di 33P con un contatore BetaplateTM. Nessun enzima e nessun valore di controllo composto vengono utilizzati per determinare la concentrazione di ZM447439, che ha dato il 50% di inibizione dell'attività enzimatica. Ulteriori dettagli sono disponibili su richiesta a Nicholas Keen.
Riferimenti
  • [4] https://pubmed.ncbi.nlm.nih.gov/21159048/

Applicazioni (Applications)

Metodi Biomarcatori Immagini PMID
Western blot p53 / p21 / p-p38 / p38 pHistone H3 / CEM BubR1 / MAD2 / Cyclin B1
S1103-WB1
23759594
Immunofluorescence p21 p53 Aurora B / Survivin
S1103-IF1
23759594